Supplement reduces risk of aflatoxin-related liver cancer

November 27, 2001

CORVALLIS, Ore. - A new clinical study has found that inexpensive daily supplements of chlorophyllin can greatly reduce the DNA damage caused by aflatoxin contamination in the diet, and could provide a practical way to prevent thousands of cases of liver cancer in some parts of the world.

The research was recently completed in China by scientists from the Johns Hopkins Bloomberg School of Public Health and Oregon State University, and published today in the professional journal Proceedings of the National Academy of Sciences.

Chlorophyllin is a derivative of the natural chlorophyll found in green vegetables and commonly available as a dietary supplement. Aflatoxins, which are known carcinogens, are produced by a fungus that is a contaminant of grains such as corn, peanuts and soybeans. Levels of aflatoxin are carefully regulated in the United States but are often far higher in the food supply of many developing nations - and are known to cause liver cancer, especially in concert with other health problems such as hepatitis.

"In the area of China in which we did our study about one in 10 adults die from liver cancer, and it's the third leading cause of cancer deaths worldwide," said George Bailey, a distinguished professor of environmental and molecular toxicology at OSU. "The findings of this research could be enormously important to many areas of China, Southeast Asia and Africa where aflatoxin-related liver cancer is a real concern. Many of these deaths might be preventable with supplements that cost pennies a day."

The double-blind study was directed by Thomas Kensler, a professor of environmental health sciences at Johns Hopkins Bloomberg School of Public Health. In it, 180 healthy adults participated from Qidong, China, a region with extraordinarily high rates of liver cancer, due in part to a diet that has high levels of carcinogenic aflatoxins. Half the study participants were given 100 milligram tablets of chlorophyllin to take three times a day with meals for four months. The other half received a placebo. After that time, samples of urine and blood revealed levels of "damage byproducts" related to aflatoxin exposure, and provided an accurate picture of how much aflatoxin damage was being done in the study participants.

The study showed that people receiving chlorophyllin had 55 percent less DNA damage related to the aflatoxin exposure in their normal diet.

According to Bailey, who directs the Marine-Freshwater Biomedical Sciences Center at OSU, research suggests that chlorophyllin acts as an "interceptor molecule" to block the absorption of aflatoxins and related carcinogens in the diet. "We first uncovered this simple protective effect in cancer studies with rainbow trout, and the present results suggest that it will be equally effective in humans," Bailey said.

According to John Groopman, professor and chairman of the Department of Environmental Health Sciences at the Johns Hopkins School of Public Health, the "study shows that chlorophyllin can effectively reduce aflatoxin levels, which should reduce the risk of liver cancer. Since chlorophyllin can be easily added to the diet, it could be a safe and effective prevention method."

There is no evidence of any harmful effects from the amounts of chlorophyllin used as supplements in this study, Bailey said. It should also be noted, he said, that the chlorophyllin compound used in this research is a derivative of chlorophyll, and it's not yet proven whether the natural chlorophyll found in foods - especially the high levels found in dark green leafy foods such as spinach and broccoli - will provide the same protection from aflatoxins as the supplements did.

In some areas of the world, Bailey said, liver cancer is a major killer, and mortality from this disease is often related both to diet and disease. People with a high level of exposure to aflatoxin in their diet have four times the rate of liver cancer as control groups, and people who have had hepatitis have seven times the risk. People who have had both hepatitis and continued exposure to dietary aflatoxin have 60 times the normal rate of liver cancer.

There is no scientific evidence that chlorophyllin supplements can be used as an effective therapy for established liver cancer or any other cancer, Bailey said. However, his research group does want to study whether these compounds may have any value in protecting against colon and smoking-related lung cancer.

This human clinical trial grew out of earlier research at OSU during the 1990s which had shown similar results with trout exposed to aflatoxins, in which dietary chlorophyllin prevented 80 percent of the liver cancers that would otherwise have formed. In this research with trout, chlorophyllin appeared to have value as a cancer preventer only if it is present in the diet at the same time as the carcinogen.

Chlorophyllin, a stable derivative of chlorophyll, is often used as a food dye or in some medicines. Many experts at OSU, including several at the university's Linus Pauling Institute, are recognized leaders in the study of chemoprevention and phytochemicals such as chlorophyll, or dietary compounds and chemicals that may have the capacity to inhibit cancer.
-end-
By David Stauth, 541-737-0787
SOURCE: George Bailey, 541-737-3164

Oregon State University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.